Our study showed that in patients with mild-to-moderate asthma, twice-daily treatment with a salmeterol/FP combination (50/100 g ), delivered via a single dry powder Diskus TM inhaler, provided ...

Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ≥12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and ...

Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ≥12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and ...

Are you searching for medications to treat 'Asthma'? Welcome to this page which serves as an archive for medications that are relevant to the treatment of Asthma. The page includes both the ...

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is low. However, when asthma control deteriorates ...

Sure, most premium products like designer bags or state-of-the-art tech tend to come with a high price tag, but there are, in fact, many extravagant gifts you can score at under $100. Oh boy ...

TRELEGY ELLIPTA contains three active ingredients: fluticasone furoate ... your doctor will limit your dose to TRELEGY ELLIPTA 100/62.5/25 micrograms once daily. being or have been treated ...

Our editors picked the 50 companies that are smartest about how they combine innovative technology with an effective business model. Some are new companies and startups, while others have ...

Your browser is out of date. Please update your browser at http://update.microsoft.com ...

Send us a tip using our anonymous form. A daily briefing on what matters in the music industry ...

billboard hot 100™ the week’s most popular current songs across all genres, ranked by streaming activity from digital music sources tracked by luminate, radio airplay audience impressions as ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...